As a part of its Launch week, Pyrls.com has integrated over 1,700 AHFS drug monographs into its platform, providing healthcare providers with comprehensive, evidence-based drug information directly accessible through the site and mobile app.
How It Works:
The AHFS monographs are integrated into Pyrls' existing interface, allowing users to search for drug information, compare formulations, and understand clinical uses without needing external resources.
Here are a few ways the new monographs can be used:
Quickly locate common side effects of oncology medications, such as Keytruda (pembrolizumab)
Navigate the complex landscape of off-label drug uses, e.g. tricyclic antidepressants
Obtain essential counseling points for specialty medications like Skyrizi (risankizumab), Tremfya (guselkumab), or Otezla (apremilast)
Compare drug formulations using detailed charts, such as a side-by-side analysis of diltiazem preparations
In Practice:
Healthcare providers can now utilize Pyrls for immediate access to detailed drug profiles during patient consultations, aiding in accurate medication dispensing, patient education, and therapeutic decision-making. Also, Pharmacies can now choose Pyrls as their preferred Drug Compendia to meet regulatory requirements.
Visit Pyrls.com to learn more.
Pyrls is a proud sponsor of Rx Radio.
